期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES LetPub Score 7.4
50 ratings
Rate
Reputation 8.7 Influence 6.4 Speed 7.0 | ||||||||||||||||||||
期刊簡稱 | JAIDS-J ACQ IMM DEF | ||||||||||||||||||||
ISSN | 1525-4135 | ||||||||||||||||||||
E-ISSN | 1944-7884 | ||||||||||||||||||||
h-index | 142 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 3.40%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://journals.lww.com/jaids/pages/default.aspx | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/JAIDS | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1999 | ||||||||||||||||||||
每年文章數 | 187每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 17.40% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-4135%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES] 的評論 | 撰寫評論 |
作者: Unjutty 領域: 審稿時間: 4.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-24 08:17:31 評論於 (0) 讚! | Unjutty |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 14:51:07 評論於 The discussion section is the core part of a SCI paper, as it can demonstrate the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. Different articles by different authors will have varying lengths for the discussion section, ranging from a few thousand words to tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 20:41:59 評論於 Does the lengthy discussion demonstrate the author's reflection on the topic? Did the reviewers have a favorable impression of the manuscript?(0) 讚! | 北国博达 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 19:35:57 評論於 What is IF?(0) 讚! | 陶宜三岁啦 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-04-05 19:44:13 評論於 It is a domineering and shameless magazine that rejects articles directly based on the opinion of an irresponsible reviewer. The specific situation is: previously, with a colleague, we submitted an article on molecular epidemiology, led by the colleague. We then conducted an evolutionary analysis using the sequences from this article and sequences from other articles, discovering some new results. The accepted article and the submitted article were completely different in terms of research content, but just because we used the sequences from the accepted article, we were accused by the reviewer of duplicate publication. Angered, I wrote a rebuttal, and after about 6 days, the editor actually said "It is our journal policy that we do not reverse our editorial decision based on honest disagreements." I don't know what "honest disagreements" even means(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-04-05 18:59:46 評論於 It is a domineering magazine, which directly rejects the submission based solely on the opinion of an irresponsible reviewer. The specific situation is: we previously collaborated with an author to submit an article on molecular epidemiology, with the author as the lead. We then used the sequences of this article, as well as sequences from other articles, to conduct evolutionary analysis and discovered some new results. The accepted article and the submitted article were completely different in terms of research content, but because we used sequences from the accepted article, we were wrongly accused by the reviewer of duplicate publication. Out of anger, we wrote a rebuttal, attached the pdf of our accepted article, and the article currently submitted for review, for the editor and reviewer to compare to determine if we were indeed guilty of duplicate publication. After about 6 days, the editor unexpectedly said, "It is our journal policy that we do not reverse our editorial decision based on honest disagreements." I don't know what "honest disagreements" means(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-07-06 22:22:37 評論於 Too difficult, try 5 times fail 5 times(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-07-06 14:46:56 評論於 Submitted once, it was rejected without passing the editorial review, saying it did not meet the magazine's standards. They probably don't appreciate Chinese articles(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us